Position paper: Breast cancer screening, diagnosis, and treatment in Denmark
Abstract Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The nationa...
Saved in:
Published in | Acta oncologica Vol. 53; no. 4; pp. 433 - 444 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.04.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010.
Material and methods. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included.
Results and conclusion. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased. |
---|---|
AbstractList | BACKGROUNDDuring the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010.MATERIAL AND METHODSBased on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included.RESULTS AND CONCLUSIONUsing incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased. Abstract Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010. Material and methods. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included. Results and conclusion. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening programme started in 1991. However, for many years only about 20% of Danish women aged 50-69 were offered screening. The national roll-out of screening took place in 2008-2010. Based on published Danish data, this overview describes the status of diagnosis and treatment, and the screening programme. For further evaluating the potential overdiagnosis and overtreatment, additional Danish Breast Cancer Cooperative Group (DBCG) data are included. Using incidence-based mortality method, reduction in breast cancer mortality was estimated to be 25% in the target group of women after 10 years of screening in Copenhagen; an outcome comparable to that of randomised controlled trials. A recent Danish study has indicated overdiagnosis to be around 4%. Others have estimated overdiagnosis to be 33%. National DBCG data showed that the rude breast cancer incidence increased during the period 1990-2011 from 126 to 206 per 100 000. The incidence was almost constant for women younger than 50 years. In regions not offering screening, the incidence increased with 3% per year for women aged 50-69 years with similar trends for small and large tumours. After introduction of screening the increase in the age group 50-69 years was confined to small tumours ≤ 20 mm, and most pronounced for node negative patients. From the 1990s, the use of breast conserving surgery has increased from around 25% to 69% in 2010. Screening has not increased the number of mastectomies. Breast cancer treatment in Denmark is evidence based and in agreement with international recommendations. After the introduction of mammography screening the absolute number of patients with a more advanced stage at diagnosis and the absolute number of patients undergoing mastectomy have decreased. |
Author | Garne, Jens Peter Møller, Susanne Lynge, Elsebeth Holten, Iben Vedsted, Peter Kroman, Niels Christiansen, Peer Vejborg, Ilse |
Author_xml | – sequence: 1 givenname: Peer surname: Christiansen fullname: Christiansen, Peer email: peerchri@rm.dk, peerchri@rm.dk organization: Breast and Endocrine Section, Department of Surgery P, Aarhus University Hospital – sequence: 2 givenname: Ilse surname: Vejborg fullname: Vejborg, Ilse email: peerchri@rm.dk, peerchri@rm.dk organization: Department of Radiology, Copenhagen University Hospital – sequence: 3 givenname: Niels surname: Kroman fullname: Kroman, Niels email: peerchri@rm.dk, peerchri@rm.dk organization: Department of Breast Surgery, Copenhagen University Hospital – sequence: 4 givenname: Iben surname: Holten fullname: Holten, Iben email: peerchri@rm.dk, peerchri@rm.dk organization: Department of Prevention and Documentation, Danish Cancer Society – sequence: 5 givenname: Jens Peter surname: Garne fullname: Garne, Jens Peter email: peerchri@rm.dk, peerchri@rm.dk organization: Department of Breast Surgery, Aalborg University Hospital – sequence: 6 givenname: Peter surname: Vedsted fullname: Vedsted, Peter email: peerchri@rm.dk, peerchri@rm.dk organization: The Research Unit for General Practice, Danish Research Centre for Cancer Diagnosis in Primary Care (CaP), School of Public Health, Aarhus University – sequence: 7 givenname: Susanne surname: Møller fullname: Møller, Susanne email: peerchri@rm.dk, peerchri@rm.dk organization: DBCG Data Center, Copenhagen University Hospital – sequence: 8 givenname: Elsebeth surname: Lynge fullname: Lynge, Elsebeth email: peerchri@rm.dk, peerchri@rm.dk organization: Department of Public Health, University of Copenhagen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24495043$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kLtOwzAUhi1URC_wBgh5ZGiKHdupw4AE5SpVgqFDN8txjtuUxil2OvD2OCplRGc4y_efyzdEPdc4QOiSkgmjJL8hqeRUZstJSiibyCkXU3aCBjQTNEnTbNlDgw5JOqaPhiFsCCEpm4oz1E85zwXhbIDmH02o2qpxeKd34G_xgwcdWmy0M-BxMB7AVW41xmWlVy7CYYy1K3EbubYG1-LK4Udwtfaf5-jU6m2Ai98-Qovnp8XsNZm_v7zN7ueJ4US2iZC5hbRMTc4EZTlnknNKjbGM6jLeZSVobqgtLHAjc1NaaQSBrOAiy4qCjdD1YezON197CK2qq2Bgu9UOmn1QVFDCY-XTiPIDanwTggerdr6Kp34rSlSnUR01qk6jOmiMsavfDfuihvIvdPQWgbsDUDnb-FqvQW_btdEe1KbZexe__3_DD6dtgx4 |
CitedBy_id | crossref_primary_10_1158_1078_0432_CCR_20_3974 crossref_primary_10_3109_0284186X_2014_920958 crossref_primary_10_1080_0284186X_2017_1281437 crossref_primary_10_1186_s12885_018_4666_1 crossref_primary_10_17116_onkolog20241301136 crossref_primary_10_3109_0284186X_2015_1128119 crossref_primary_10_1002_cncr_29020 crossref_primary_10_1016_j_acra_2015_10_002 crossref_primary_10_3109_0284186X_2014_920961 crossref_primary_10_1002_cam4_6436 crossref_primary_10_1186_s13058_021_01480_1 crossref_primary_10_1002_ijc_30924 crossref_primary_10_4048_jbc_2016_19_4_447 crossref_primary_10_3109_0284186X_2015_1115118 crossref_primary_10_1245_s10434_016_5295_z crossref_primary_10_3390_ijerph14040452 crossref_primary_10_1097_AIA_0000000000000119 crossref_primary_10_1245_s10434_015_5041_y crossref_primary_10_1002_ijc_32354 crossref_primary_10_1016_j_acra_2015_03_003 crossref_primary_10_1007_s00330_015_3849_2 crossref_primary_10_3390_medicina58070882 crossref_primary_10_1001_jamanetworkopen_2022_48980 |
Cites_doi | 10.1080/02841860802027009 10.1136/bmj.38313.639236.82 10.1136/bmj.c1241 10.7326/0003-4819-137-5_Part_1-200209030-00005 10.1016/S0960-9776(03)00031-6 10.1136/bmj.f1064 10.1258/096914107781261918 10.1080/02841860410002789 10.1186/bcr1625 10.1038/bjc.2013.6 10.1056/NEJMoa1206809 10.3109/0284186X.2011.599339 10.1016/j.ejca.2009.06.014 10.1038/sj.bjc.6604203 10.1016/S1470-2045(11)70250-9 10.1016/S0140-6736(10)62231-3 10.1056/NEJMoa1000727 10.1001/archinte.168.21.2311 10.1016/S0140-6736(12)61611-0 10.1111/j.1075-122X.2006.00272.x 10.1136/bmj.38764.572569.7C 10.1080/02841860802043931 10.1258/jms.2012.012077 10.1002/cncr.21823 10.1177/0969141313495190 10.1016/j.ejca.2004.01.005 10.1002/ijc.20604 10.1093/epirev/mxr009 10.1093/jnci/92.18.1490 10.1258/jms.2009.009094 10.1158/1055-9965.EPI-07-0262 10.1186/1472-6874-9-36 10.7326/0003-4819-151-10-200911170-00009 10.3109/0284186X.2012.698750 10.1093/annonc/mdm481 |
ContentType | Journal Article |
Copyright | 2014 Informa Healthcare 2014 |
Copyright_xml | – notice: 2014 Informa Healthcare 2014 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.3109/0284186X.2013.874573 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1651-226X |
EndPage | 444 |
ExternalDocumentID | 10_3109_0284186X_2013_874573 24495043 |
Genre | Journal Article Review |
GeographicLocations | Denmark |
GeographicLocations_xml | – name: Denmark |
GroupedDBID | --- .55 .GJ 00X 03L 0BK 0R~ 23M 2WC 36B 3O- 4.4 53G 5GY 5RE 5VS 6J9 AAJNR AALIY AALUX AAPUL AAPXX AAWTL ABBKH ABDBF ABEIZ ABFIM ABJNI ABLJU ABLKL ABUPF ABWCV ABXYU ABZEW ACENM ACFUF ACGEJ ACGFO ACGFS ACKZS ACLSK ADBBV ADCVX ADFCX ADFOM ADFZZ ADRBQ ADXPE AECIN AEGXH AEIIZ AENEX AEOZL AEXWM AEYQI AFFNX AFKVX AFLEI AFWLO AGDLA AGYJP AHPSJ AIAGR AIJEM AIRBT AJVHN AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AWYRJ BABNJ BAWUL BLEHA BOHLJ BRMBE CAG CCCUG COF CS3 CYYVM CZDIS DIK DKSSO DRXRE DWTOO EAP EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EPL ESX F5P GX1 HZ~ JENTW KRBQP KSSTO KWAYT KYCEM L7B LJTGL M44 M4Z O9- OK1 OVD P2P RNANH SV3 TEORI TFDNU TFL TFW TUS UEQFS V1S WH7 X7M ZA5 ZGI ZXP ~1N AAMIU ABLIJ ABNNA ACCJX ACIEZ AFPKN AGFJD ALYBC CGR CUY CVF ECM EIF GROUPED_DOAJ H13 NPM NUSFT PGMZT RPM TBQAZ TDBHL TERGH AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c408t-589fe2d2c9351394384411ccf31ad950f8ea4c1fbfe4c89cdf8c50e6b4566bb3 |
ISSN | 0284-186X |
IngestDate | Thu Aug 15 23:24:48 EDT 2024 Thu Sep 12 17:36:06 EDT 2024 Sat Sep 28 08:00:25 EDT 2024 Wed Jan 31 10:30:17 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c408t-589fe2d2c9351394384411ccf31ad950f8ea4c1fbfe4c89cdf8c50e6b4566bb3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://figshare.com/articles/journal_contribution/Position_paper_Breast_cancer_screening_diagnosis_and_treatment_in_Denmark/1568162/1/files/2349824.pdf |
PMID | 24495043 |
PQID | 1510404097 |
PQPubID | 23479 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_1510404097 crossref_primary_10_3109_0284186X_2013_874573 pubmed_primary_24495043 informahealthcare_journals_10_3109_0284186X_2013_874573 |
PublicationCentury | 2000 |
PublicationDate | 2014-04-01 |
PublicationDateYYYYMMDD | 2014-04-01 |
PublicationDate_xml | – month: 04 year: 2014 text: 2014-04-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Acta oncologica |
PublicationTitleAlternate | Acta Oncol |
PublicationYear | 2014 |
Publisher | Informa Healthcare |
Publisher_xml | – name: Informa Healthcare |
References | 24881500 - Acta Oncol. 2015 Jan;54(1):133-4 24881501 - Acta Oncol. 2015 Jan;54(1):135-6 CIT0030 CIT0032 CIT0031 CIT0012 CIT0034 CIT0011 CIT0033 Richards C (CIT0038) 2011; 169 Larsen SU (CIT0039) 1999; 161 CIT0014 CIT0036 CIT0013 CIT0035 CIT0016 CIT0015 CIT0037 CIT0018 CIT0017 CIT0019 CIT0041 CIT0021 CIT0020 CIT0001 CIT0023 CIT0022 Christensen LH (CIT0040) 2001; 163 Vejborg I (CIT0010) 2012; 174 CIT0003 CIT0025 CIT0002 CIT0024 CIT0005 CIT0027 CIT0004 CIT0026 CIT0007 CIT0029 CIT0006 CIT0028 CIT0009 CIT0008 |
References_xml | – ident: CIT0003 doi: 10.1080/02841860802027009 – ident: CIT0019 doi: 10.1136/bmj.38313.639236.82 – ident: CIT0020 doi: 10.1136/bmj.c1241 – ident: CIT0023 doi: 10.7326/0003-4819-137-5_Part_1-200209030-00005 – volume: 163 start-page: 2774 year: 2001 ident: CIT0040 publication-title: Ugeskr Laeger contributor: fullname: Christensen LH – ident: CIT0015 doi: 10.1016/S0960-9776(03)00031-6 – ident: CIT0011 – ident: CIT0033 doi: 10.1136/bmj.f1064 – ident: CIT0016 doi: 10.1258/096914107781261918 – ident: CIT0005 doi: 10.1080/02841860410002789 – ident: CIT0029 doi: 10.1186/bcr1625 – volume: 174 start-page: 2533 year: 2012 ident: CIT0010 publication-title: Ugeskr Laeger contributor: fullname: Vejborg I – ident: CIT0006 doi: 10.1038/bjc.2013.6 – ident: CIT0036 doi: 10.1056/NEJMoa1206809 – ident: CIT0018 doi: 10.3109/0284186X.2011.599339 – ident: CIT0030 doi: 10.1016/j.ejca.2009.06.014 – ident: CIT0014 doi: 10.1038/sj.bjc.6604203 – volume: 169 start-page: 996 year: 2011 ident: CIT0038 publication-title: Arch Intern Med contributor: fullname: Richards C – ident: CIT0041 doi: 10.1016/S1470-2045(11)70250-9 – ident: CIT0002 doi: 10.1016/S0140-6736(10)62231-3 – ident: CIT0017 doi: 10.1056/NEJMoa1000727 – ident: CIT0037 doi: 10.1001/archinte.168.21.2311 – volume: 161 start-page: 4001 year: 1999 ident: CIT0039 publication-title: Ugeskr Laeger contributor: fullname: Larsen SU – ident: CIT0013 doi: 10.1016/S0140-6736(12)61611-0 – ident: CIT0031 doi: 10.1111/j.1075-122X.2006.00272.x – ident: CIT0022 doi: 10.1136/bmj.38764.572569.7C – ident: CIT0034 doi: 10.1080/02841860802043931 – ident: CIT0035 doi: 10.1258/jms.2012.012077 – ident: CIT0021 doi: 10.1002/cncr.21823 – ident: CIT0025 doi: 10.1177/0969141313495190 – ident: CIT0004 doi: 10.1016/j.ejca.2004.01.005 – ident: CIT0007 doi: 10.1002/ijc.20604 – ident: CIT0026 doi: 10.1093/epirev/mxr009 – ident: CIT0024 doi: 10.1093/jnci/92.18.1490 – ident: CIT0028 doi: 10.1258/jms.2009.009094 – ident: CIT0027 doi: 10.1158/1055-9965.EPI-07-0262 – ident: CIT0032 doi: 10.1186/1472-6874-9-36 – ident: CIT0012 doi: 10.7326/0003-4819-151-10-200911170-00009 – ident: CIT0001 – ident: CIT0008 doi: 10.3109/0284186X.2012.698750 – ident: CIT0009 doi: 10.1093/annonc/mdm481 |
SSID | ssj0002375 |
Score | 2.2319407 |
SecondaryResourceType | review_article |
Snippet | Abstract
Background. During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first... During the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography screening... BACKGROUNDDuring the last decades the diagnosis, treatment, and prognosis of breast cancer have changed and improved in Denmark. The first mammography... |
SourceID | proquest crossref pubmed informahealthcare |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 433 |
SubjectTerms | Breast Neoplasms - diagnosis Breast Neoplasms - prevention & control Breast Neoplasms - therapy Denmark Female Humans Mammography Mass Screening |
Title | Position paper: Breast cancer screening, diagnosis, and treatment in Denmark |
URI | https://www.ncbi.nlm.nih.gov/pubmed/24495043 https://search.proquest.com/docview/1510404097 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWVkJcqvLeFpCRuLUuG9t5uLcuULVAqx4WtLco9jrqIsiuSvbCD-jv7kzsOIGWVy_RKrLjrOfLeGx_85mQV7E0qUYFgIinJZOJNUynvGDc6FTaWBU8wnznk9Pk6JN8P42ng8Flj7W0qvWe-XFjXsltrAr3wK6YJfsflg0PhRvwG-wLV7AwXP_JxmeecbWzLJa2Oe9xjBzzGqlcBmWaDbJq_KklM0eqc5oCDW8ycMznFfid6lubttOK0pq62FlUxrvHjgjg_YJfuzmzHcH3s_0CmGqaO_7abft8uFj4hdbTuZNvbtMhaveMY-0z0vz6Q9SnrSyvZU0hXa3nwWDsY1HWHFUIg43zsEkcMYj5pn0X7PSCPdRkz59Kp5Lhh2bppCJ_9frCiaZia9gY8vXEHsr4p6Ib5QL3EGY9WCFvi-dYPHfF75B1nqoYJvHrB-O348MwpnPRSDaHP-SSMPE5r29q9qcgZ9NL4J6HHvr9bKaJaiabZMNPR-iBw9Z9MrDVA3L3xBMuHpKPLcRoA7F96gBGHcBoANguDfDapQAuGsBF5xX14HpEJofvJm-OmD-Agxk5ymoWZ6q0fMaNEjHMFKTIIHiOjClFVMxUPCozW0gTlbq00mTKzMrMxCObaIjKE63FY7JWLSr7lFAtSgh1Nce8ZZkarTKjONdWyWZv1w4JazssXzqZlfxPhhqS9Fqv5v7L_P6Xmi_bvs_Bk-L2WFHZxQpqwfAkR6j_NiRPnFHCu0AQrFDrb-vW7W6Te93X84ys1Rcr-xzi2Vq_8GC7AjfpmIk |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Position+paper%3A+Breast+cancer+screening%2C+diagnosis%2C+and+treatment+in+Denmark&rft.jtitle=Acta+oncologica&rft.au=Christiansen%2C+Peer&rft.au=Vejborg%2C+Ilse&rft.au=Kroman%2C+Niels&rft.au=Holten%2C+Iben&rft.date=2014-04-01&rft.pub=Informa+Healthcare&rft.issn=0284-186X&rft.eissn=1651-226X&rft.volume=53&rft.issue=4&rft.spage=433&rft.epage=444&rft_id=info:doi/10.3109%2F0284186X.2013.874573&rft.externalDocID=10_3109_0284186X_2013_874573 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0284-186X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0284-186X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0284-186X&client=summon |